Emotional Recovery Post-Stroke
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Jan 16, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Emotional Recovery Post-Stroke" clinical trial is looking to see if adding emotional wellness support to existing therapy programs can help people who have had a stroke feel better emotionally and participate more in daily activities. Participants in this study will take part in telerehabilitation, which means they will receive therapy through video calls from the comfort of their own homes. This study aims to help individuals who have experienced a stroke and are dealing with emotional challenges such as anxiety, sadness, or sleep problems.
To be eligible for this trial, participants should be at least 21 years old, have had a stroke at least 30 days prior, and be able to communicate in English. They should also have some difficulties with emotional wellness related to their stroke, like feeling fearful or losing hope. Participants will need to have a device like a smartphone or tablet and a good internet connection to join the sessions. It’s important to note that people who have significant pain affecting movement or who are unable to follow simple instructions will not be able to participate. Overall, this study could provide valuable insights into how emotional support can enhance recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-reported stroke-related deficits in emotional wellness such as anxiety, sleep disturbance, dread, fear, loss of hope, sadness.
- • Have experienced ischemic or hemorrhagic stroke at least 30 days prior
- • Stroke-related aphasia and/or upper extremity hemiparesis
- • Aged 21 years or older
- • English as primary language
- • Have corrected vision to be able to read text on a screen
- • Able to participate fully in the study's tele-rehabilitation (Aim 1) and/or virtual group programing (Aim 2) with personally owned device (i.e., phone, tablet, or laptop) and personal Wi-Fi connection or cellular service
- • Cognitive, language, and motor capacity to participate fully in the study's assessment session as per the judgment of the licensed, experienced stroke tele-rehabilitation occupational or speech therapist
- Exclusion Criteria:
- • Unable to follow 1-2 step instructions given by the study team member during the informed consent procedures.
- • Pain that interferes with ability to participate in the study's upper extremity movement tasks.
- • Have impaired decision making capacity as determined by the U-ARE protocol for assessing capacity to provide informed consent.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Michelle Woodbury, PhD
Principal Investigator
Medical University of South Carolina
Lisa McTeague, PhD
Principal Investigator
Medical University of South Carolina
Deena Blackett, PhD
Principal Investigator
University of Central Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported